Herbert Waldmann

Professor Herbert Waldmann, based at the Max Planck Institute of Molecular Physiology and Technical University of Dortmund, serves as Director of the Department of Chemical Biology and Head of the Chemical Genomics Centre of the Max Planck Society. He holds a full professorship in biochemistry at TU Dortmund University.

• PhD in Organic Chemistry (University of Mainz, 1985)
• Postdoctoral work with George Whitesides at Harvard University (1985-1986)
• Habilitation at University of Mainz (1986-1991)

Waldmann's research integrates chemical biology, organic synthesis, and biochemical pathway analysis to develop innovative small molecule probes and therapeutic candidates targeting key cellular processes. His work on pseudo-natural products and target-specific inhibitors has transformed chemical biology approaches.

Analysis of his 15 most recent publications reveals expertise in RNA-targeted degraders, cholesterol homeostasis, glucose transporter inhibition, and signaling pathway modulation across cancer biology, autophagy, and neurodegenerative disease mechanisms.

• Emil Fischer Medal (GDCh)
• ERC Advanced Investigator Grant
• Wilhelm-Manchot Fellowship
• Paul Karrer Medal
• Max Bergmann Medal

With over 500 publications and 20 years of industrial collaboration experience, Waldmann's interdisciplinary research bridges academic discovery and pharmaceutical development while maintaining rigorous scientific integrity. His leadership extends to editorial roles at Angewandte Chemie and Bioorganic and Medicinal Chemistry, plus advisory positions at Max Planck Innovation GmbH and European Institute of Chemistry and Biology.